Results 21 to 30 of about 2,141 (171)

Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review

Health Science Reports, Volume 5, Issue 5, September 2022., 2022
Abstract COVID‐19 is not only limited to a defined array but also has expanded with several secondary infections. Two uncommon opportunistic fungal infections, COVID‐19 associated mucormycosis (CAM) and aspergillosis (CAA), have recently been highly acquainted by many worldwide cases.
Prodip Kumar Baral, Md. Abdul Aziz, Mohammad Safiqul Islam   +2 more
wiley   +1 more source

Current situation of fungal diseases in Eritrea

Mycoses, Volume 65, Issue 8, Page 806-814, August 2022., 2022
Abstract The epidemiology of fungal infections in Eritrea is unknown. Most cases are under‐reported due to a lack of diagnostics. This study estimates the burden of serious fungal infections and highlights treatment and diagnostic gaps in the country.
Sara Werkneh, Emma Orefuwa, David W. Denning   +2 more
wiley   +1 more source

Rapidly Fatal Pulmonary Mucormycosis With Pericardial Dissemination: A Case Report and Imaging Insights. [PDF]

Case Rep Infect Dis
Mucormycosis is a rare but aggressive opportunistic fungal infection, predominantly affecting immunocompromised individuals. We report a case of a 59‐year‐old male with newly diagnosed acute myeloid leukemia undergoing chemotherapy who developed pulmonary mucormycosis, which rapidly progressed to disseminated disease with pericardial involvement, an ...
Rahmatullah ZF, Kawamoto S, Fishman EK.
europepmc   +2 more sources

Treatment and economic burden of mucormycosis in China: Case report review and burden estimation

Journal of Clinical Pharmacy and Therapeutics, Volume 47, Issue 7, Page 905-914, July 2022., 2022
The burden estimation of mucormycosis in China shows that drug cost has the highest proportion of total cost (cost/10,000 CNY, type of cost, proportion%). More than 90% of the total cost is direct medical cost, and drug cost is the highest (63.9%) of them followed by inpatient charges during first hospitalization at almost 20%.
Yifei Jian, Minggui Wang, Yue Yu, Yongjia Zhuo, Dunming Xiao, Sisi Lin, Jianwei Xuan   +6 more
wiley   +1 more source

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

Medical Mycology Case Reports, 2017
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku   +8 more
doaj   +1 more source

Let's talk about sex characteristics—As a risk factor for invasive fungal diseases

Mycoses, Volume 65, Issue 6, Page 599-612, June 2022., 2022
Abstract Biological sex, which comprises differences in host sex hormone homeostasis and immune responses, can have a substantial impact on the epidemiology of infectious diseases. Comprehensive data on sex distributions in invasive fungal diseases (IFDs) are lacking. In this review, we performed a literature search of in vitro/animal studies, clinical
Matthias Egger, Martin Hoenigl, George R. Thompson III, Agostinho Carvalho, Jeffrey D. Jenks   +4 more
wiley   +1 more source

Subcutaneous zygomycosis: A diagnostic and therapeutic challenge

Indian Journal of Paediatric Dermatology, 2022
Subcutaneous zygomycosis is a rare deep fungal infection caused by a group of fungus belonging to the order Entomophtharales. It is a saprophytic fungus and the predominant species causing the infection includes Basidiobolus ranarum and Conidiobolus ...
Ketki Chaudhary, Kritika Agrawal, Vijay Paliwal, Puneet Bhargava, Deepak Kumar Mathur   +4 more
doaj   +1 more source

Managing mucormycosis in diabetic patients: A case report with critical review of the literature

Oral Diseases, Volume 28, Issue 3, Page 568-576, April 2022., 2022
Abstract Background and Purpose Rhino–orbito–cerebral mucormycosis (ROCM) is a rare and potentially fatal invasive fungal infection which usually occurs in diabetic and other immunocompromised patients. This infection is associated with high morbidity and mortality rates.
Fabian M. Beiglboeck, Nantia E. Theofilou, Matthias D. Fuchs, Matthias G. Wiesli, Christoph Leiggener, Sebastian Igelbrink, Marcello Augello   +6 more
wiley   +1 more source

Gastrointestinal Zygomycosis Masquerading as Acute Appendicitis

Case Reports in Gastroenterology, 2016
Zygomycosis is a rare invasive opportunistic fungal infection that occurs in the setting of hematologic malignancies, chemotherapy-induced neutropenia, and immunosuppressive therapies.
Won-Tak Choi, Tammy T. Chang, Ryan M. Gill   +2 more
doaj   +1 more source

Invasive Zygomycosis: Epidemiology and Clinical Features (Review)

Клиническая онкогематология, 2016
The invasive zygomycosis is the third most common mycosis following invasive candidiasis and aspergillosis. Patients with hematological malignancies and patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) are two main risk ...
Nataliya Sergeevna Bagirova
doaj   +1 more source